Background Chloroquine, a previous highly efficacious, easy to use and affordable anti-
malarial agent was withdrawn from malaria endemic regions due to high levels of …

Background Translating genomic technologies into healthcare applications for the malaria
parasite Plasmodium falciparum has been limited by the technical and logistical difficulties …

Background Plasmodium falciparum resistance to series of anti-malarial drugs is a major
challenge in efforts to control and/or eliminate malaria globally. In 1998, following the …

ABSTRACT A key drawback to monitoring the emergence and spread of antimalarial drug
resistance in sub-Saharan Africa is early detection and containment. Next-generation …

Malaria is a significant public health problem in Ghana. Seasonal Malaria Chemoprevention
(SMC) using a combination of sulfadoxine-pyrimethamine and amodiaquine has been …

Background Anti-malarial herbal preparations (HPs) continue to enjoy high patronage in
Ghana despite reports that the artemisinin-based combination therapy (ACT), the …

Background Because of the loss of chloroquine (CQ) effectiveness, the Democratic Republic
of Congo (DRC)'s malaria treatment policy replaced CQ by sulfadoxine–pyrimethamine (SP) …

Overdiagnosis and overtreatment of malaria is a major problem in children in malaria-
endemic countries. This retrospective study identified children who were admitted with fever …

Malaria infections undetectable by microscopy but detectable by Polymerase Chain
Reaction (PCR)(submicroscopic malaria) are common in endemic areas like Ghana …

Background Malaria control efforts in Ghana have reduced the countrywide average malaria
prevalence from 71% in 2000 to about 51% in 2012; however, its main focus is on …